“We’re in a frothy time,” acknowledges Alexandra Snyder, the head of R&D at Generate:Biomedicines.
Generate is one of the AI-driven biotechs that make up a new generation of companies with huge funding, A-list science and tech stars and computing horsepower. On Tuesday, the $1 billion-plus launch of…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
